• Bintrafusp Alfa Versus Pembrolizumab in Patients With Treatment-Naive, Programmed Death-Ligand 1–High Advanced NSCLC: A Randomized, Open-Label, Phase 3 Trial 

  Cho, Byoung Chul; Lee, Jong Seok; Wu, Y. L.; Çiçin, Irfan; Ahn, Myung-Ju; cobo, manuel; FELIP, ENRIQUETA (Elsevier, 2023-12)

• Safety, Efficacy, and Biomarker Analyses of Dostarlimab in Patients with Endometrial Cancer: Interim Results of the Phase I GARNET Study 

  Pothuri, Bhavana; Gilbert, Lucy; Brown, Jubilee; Ghamande, Sharad; OAKNIN, ANA; Sabatier, Renaud (American Association for Cancer Research, 2023-11-15)

• Three-dimensional cell culture of chimeric antigen receptor T cells originated from peripheral blood mononuclear cells towards cellular therapies 

  Pérez del Río, Eduardo; Roman Alonso, Macarena; Rius Ruiz, Irene; Santos, Fabião; Castellote Borrell, Miquel; Veciana, Jaume; Arribas, Joaquin (Elsevier, 2023-12)

• Large-scale meta-genome-wide association study reveals common genetic factors linked to radiation-induced acute toxicities across cancer types 

  Naderi, Elnaz; Schack, Line Meinertz Hybel; Dorling, Leila; Rattay, Tim; Ramos Albiac, Monica; Aguado-Barrera, Miguel E; Fachal, Laura; Altabas González, Manuel; Gutiérrez-Enríquez, Sara; Molla, Meritxell; Reyes López, Victoria; Giraldo Marin, Alexandra (Oxford University Press, 2023-12)

• Antitumor Activity and Safety of Dostarlimab Monotherapy in Patients With Mismatch Repair Deficient Solid Tumors: A Nonrandomized Controlled Trial 

  André, Thierry; Berton, Dominique; Curigliano, Giuseppe; Sabatier, Renaud; Tinker, Anna; OAKNIN, ANA (American Medical Association, 2023-11)

Més